Modeling the Prediction on the Efficacy of a Homologous Third Dose of CoronaVac Against SARS-CoV-2 Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 - China, 2020-2021.

Chen, Xinhua; Bai, Xufang; Chen, Xinghui; Zheng, Nan; Yang, Juan; Zhang, Juanjuan; Yu, Hongjie

Chen, Xinhua; Bai, Xufang; Chen, Xinghui; Zheng, Nan; Yang, Juan; Zhang, Juanjuan; Yu, Hongjie.

Afiliación

Chen X; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.
Bai X; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.
Chen X; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.
Zheng N; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.
Yang J; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.
Zhang J; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai Municipality, China.
Yu H; Shanghai Huashen Institute of Microbes and Infections, Shanghai Municipality, China.

China CDC Wkly ; 5(5): 103-107, 2023 Feb 03.

Article en En | MEDLINE | ID: mdl-37006710

Palabras clave

CoronaVac; Prediction; SARS-CoV-2 Omicron; Vaccine efficacy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: China CDC Wkly Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google